WTAP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.640800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.196350E-02
Normal-vs-Stage2
5.381600E-03
Normal-vs-Stage3
1.505510E-02
Normal-vs-Stage4
1.060240E-01
Stage1-vs-Stage2
3.189600E-01
Stage1-vs-Stage3
8.401600E-01
Stage1-vs-Stage4
1.191410E-01
Stage2-vs-Stage3
5.575800E-01
Stage2-vs-Stage4
2.485200E-01
Stage3-vs-Stage4
1.553780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.475500E-03
Normal-vs-AfricanAmerican
2.647700E-02
Normal-vs-Asian
2.396000E-03
Caucasian-vs-AfricanAmerican
8.676200E-01
Caucasian-vs-Asian
1.025790E-01
AfricanAmerican-vs-Asian
2.280600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.737000E-03
Normal-vs-Female
5.337900E-03
Male-vs-Female
3.227200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.275690E-02
Normal-vs-Age(41-60Yrs)
5.365000E-03
Normal-vs-Age(61-80Yrs)
3.803400E-03
Normal-vs-Age(81-100Yrs)
1.684050E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.358200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.207600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.992200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.272400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.511200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.234000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.357280E-03
Normal-vs-Daily Drinker
6.555500E-03
Normal-vs-Weekly Drinker
7.939500E-03
Normal-vs-Occasional Drinker
8.422200E-03
Normal-vs-Social Drinker
1.656120E-03
Non Drinker-vs-Daily Drinker
9.698400E-01
Non Drinker-vs-Weekly Drinker
6.537200E-01
Non Drinker-vs-Occasional Drinker
3.268600E-01
Non Drinker-vs-Social Drinker
3.463000E-01
Daily Drinker-vs-Weekly Drinker
6.806600E-01
Daily Drinker-vs-Occasional Drinker
3.847200E-01
Daily Drinker-vs-Social Drinker
4.049200E-01
Weekly Drinker-vs-Occasional Drinker
6.856800E-01
Weekly Drinker-vs-Social Drinker
6.995400E-01
Occasional Drinker-vs-Social Drinker
9.581800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.083000E-01
Normal-vs-Grade 2
7.197800E-01
Normal-vs-Grade 3
7.814800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.813200E-01
Grade 1-vs-Grade 3
8.938800E-01
Grade 1-vs-Grade 4
5.083000E-01
Grade 2-vs-Grade 3
2.297800E-01
Grade 2-vs-Grade 4
7.197800E-01
Grade 3-vs-Grade 4
7.814800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.892020E-02
Normal-vs-NonDiabetic
7.786500E-04
Diabetic-vs-NonDiabetic
6.669200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.804800E-04
Normal-vs-NoPancreatitis
3.922100E-03
Pancreatitis-vs-NoPancreatitis
4.096800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.600200E-03
Normal-vs-N1
6.178500E-03
N0-vs-N1
3.569400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.244760E-03
Normal-vs-TP53-NonMutant
1.860250E-02
TP53-Mutant-vs-TP53-NonMutant
3.998000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
